[2]
The applicants AB Hassle, AstraZeneca AB and AstraZeneca Canada Inc. (collectively Astra) and the respondent Takeda, pursuant to rule 403 of the
Federal Court Rules
, 1998, request an order providing directions to the assessment officer regarding the assessment of costs. Specifically, they request that I direct that costs be assessed in accordance with the highest end of column V of Tariff B. They additionally request that directions issue to the assessment officer regarding various items of the tariff. In the alternative, they seek an extension of time to bring the motion under rule 397. At the hearing, counsel indicated that, while not withdrawing the alternative request, the applicants were "hanging their hat" on rule 403.
The motion under rule 397